Literature DB >> 6974176

Marker profiles of human leukemia and lymphoma cell lines.

J Minowada, H Koshiba, K Sagawa, I Kubonishi, M S Lok, E Tatsumi, T Han, B I Srivastava, T Ohnuma.   

Abstract

By means of the multiple marker analysis, a total of 55 human leukemia-lymphoma cell lines which included 15 T-cell, 30 B-cell, four myelomonocytic-cell, and six non-T, non-B cell lines was characterized for their marker profiles. The multiple markers used included a number of cell surface markers as detected by either rosette or immunofluorescence tests, enzyme assays, cytogenetic analysis, and certain functional assay. Based on the criteria previously defined it was found that all the cell lines were proved to represent original leukemia-lymphoma of ALL, AML, CLL, CML in blastic phase or variety of lymphomas. The monoclonality, a "frozen" state at a specific state of differentiation-maturation, and cytogenetic marker in each leukemia-lymphoma cell line were remarkable common properties and were stable for years of cultivation. Similar, if not identical, general characteristics were observed in the study on 344 cases of uncultured fresh leukemia-lymphomas by the multiple marker analysis. While no single marker specific to any type of tumor was found, the study offers not only a basis for better understanding of the biology of leukemia-lymphoma but also an insight into normal hematopoietic cell differentiation in man.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6974176     DOI: 10.1007/BF00405069

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  27 in total

1.  Antisera to acute lymphoblastic leukemia cells.

Authors:  M F Greaves; G Brown; N T Rapson; T A Lister
Journal:  Clin Immunol Immunopathol       Date:  1975-05

2.  Establishment and characterization of human B-lymphocytic lymphoma cell lines (BALM-3, -4 and -5); intraclonal variation in the B-cell differentiation stage.

Authors:  M S Lok; H Koshiba; T Han; S Abe; J Minowada; A A Sandberg
Journal:  Int J Cancer       Date:  1979-11-15       Impact factor: 7.396

3.  Alloantigens of human lymphoid cell lines; 'human Ia-like antigens'. Alloantigenic activity and cell line, organ and tissue distribution as determined by radioimmunoassay.

Authors:  K Koyama; K Nakamuro; N Tanigaki; D Pressman
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

4.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

5.  Cell line derived from patient with myeloma.

Authors:  G E Moore; H Kitamura
Journal:  N Y State J Med       Date:  1968-08-01

Review 6.  Tumor-associated antigens of human leukemia cells.

Authors:  R S Metzgar; T Mohanakumar
Journal:  Semin Hematol       Date:  1978-04       Impact factor: 3.851

7.  Differentiation linked expression of p28,33 (Ia-like) structures on human leukaemic cells.

Authors:  G Janossy; A H Goldstone; D Capellaro; M F Greaves; J Kulenkampff; M Pippard; K Welsh
Journal:  Br J Haematol       Date:  1977-11       Impact factor: 6.998

8.  Distribution of Ia-like molecules on the surface of normal and leukemic human cells.

Authors:  S F Schlossman; L Chess; R E Humphreys; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

9.  Blast crisis of chronic myeloid leukaemia (CML). II. Cell surface marker analysis of "lymphoid" and myeloid cases.

Authors:  G Janossy; M F Greaves; T Revesz; T A Lister; M Roberts; J Durrant; B Kirk; D Catovsky; M E Beard
Journal:  Br J Haematol       Date:  1976-10       Impact factor: 6.998

10.  Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.

Authors:  S J Collins; F W Ruscetti; R E Gallagher; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

View more
  11 in total

1.  NALL-1, an acute lymphoblastic leukemia cell line with peroxidase activity.

Authors:  J Yourno; W A Samsonoff; A Willey; P Burkhart; F Lizzi; A Tartaglia
Journal:  In Vitro       Date:  1984-11

2.  Specific expression of the human cellular fps/fes-encoded protein NCP92 in normal and leukemic myeloid cells.

Authors:  R A Feldman; J L Gabrilove; J P Tam; M A Moore; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

3.  T-cell receptor alpha-chain gene is split in a human T-cell leukemia cell line with a t(11;14)(p15;q11).

Authors:  M M Le Beau; T W McKeithan; E A Shima; R E Goldman-Leikin; S J Chan; G I Bell; J D Rowley; M O Diaz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

4.  Monoclonal antibody that defines a unique human T-cell leukemia antigen.

Authors:  B K Seon; S Negoro; M P Barcos
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

5.  Distinct human leukemia-associated cell surface glycoprotein GP160 defined by monoclonal antibody SN6.

Authors:  Y Haruta; B K Seon
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

6.  Cystathionase: a potential cytoplasmic marker of hematopoietic differentiation.

Authors:  D Link; C Drebing; L M Glode
Journal:  Blut       Date:  1983-07

7.  An industry wide mortality study of chemical workers occupationally exposed to benzene. I. General results.

Authors:  O Wong
Journal:  Br J Ind Med       Date:  1987-06

Review 8.  Critical assessment of epidemiologic studies on the human carcinogenicity of 1,3-butadiene.

Authors:  P J Landrigan
Journal:  Environ Health Perspect       Date:  1990-06       Impact factor: 9.031

9.  CSL-MAML-dependent Notch1 signaling controls T lineage-specific IL-7R{alpha} gene expression in early human thymopoiesis and leukemia.

Authors:  Sara González-García; Marina García-Peydró; Enrique Martín-Gayo; Esteban Ballestar; Manel Esteller; Rafael Bornstein; José Luis de la Pompa; Adolfo A Ferrando; María L Toribio
Journal:  J Exp Med       Date:  2009-04-06       Impact factor: 14.307

10.  Induction of HLA-DC/DS (LEU 10) antigen expression by human precursor B cell lines.

Authors:  C Y Wang; A Al-Katib; C L Lane; B Koziner; S M Fu
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.